*Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Bethesda, MD 20892; †Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN; ‡Massachusetts General Hospital, Boston, MA; §Vanderbilt University, Nashville, TN; **New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY; ††University of Missouri, Columbia Nuclear Medicine program, Columbia, MO; ‡‡Nuclear Medicine and Radiation Service, Department of Veterans Affairs Health System, Ann Arbor, MI; §§Department of Veterans Affairs Health System, Palo Alto, CA; ***Retired; †††Beth Israel Deaconess Medical Center, Boston, MA; ‡‡‡University of Iowa Hospitals and Clinics, Iowa City, IA; §§§Veterans Affairs Northport, Long Island, NY; ****Center for Countermeasures against Radiation, Lovelace Respiratory Research Institute, Albuquerque, NM.
The authors declare no conflicts of interest.
For correspondence contact: Vladimir Drozdovitch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Room 7E548 MSC 9778, Bethesda MD 20892‐9778, or email at [email protected].
(Manuscript accepted 3 November 2014)